Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2009
12/02/2009CN101591332A Compound based on 4-phenyl-6-(2, 2, 2-trifluoro-1-phenylethoxy) pyridine and application method thereof
12/02/2009CN101591281A Phosphonate compounds having immuno-modulatory activity
12/02/2009CN100564378C Pyrrolidine oxadiazole- and thiadiazole derivatives
12/02/2009CN100564375C (3Z) -3-(2,3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
12/01/2009US7626040 Substituted imidazole compounds as KSP inhibitors
12/01/2009US7626033 Compounds for the modulation of PPARγ activity
12/01/2009US7626032 4-Amino-3,3-dimethylpiperidine; reduced toxicity, and improved pharmacology and pharmacokinetics
12/01/2009US7626031 5-[(1-Ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)(1H-imidazol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one; antiproliferative agents; modulating cell differentiation,migration, and chemoinvasion; endothelial growth factor-modulated diseases; antiarthritic agents; graft versus host diseases
12/01/2009US7626030 Compounds and methods of use
12/01/2009US7625933 PPAR gamma agonists or partial agonists; type II diabetes, including hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity; compounds have a thiazolidinedione or an oxazolidinedione substituent
12/01/2009US7625932 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
12/01/2009US7625914 2(S)-Ethoxy-3-{4-[2-(3-heptyl-1-methylureido)thiazol-4-yl]phenyl}propanoic acid; dermatology, and cardiovascular diseases, immune diseases, lipid metabolism diseases; veterinary medicine
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009US7625908 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
12/01/2009US7625901 for treating migraine, headaches; 2-[(8S)-8-(3,5-Difluorophenyl)-6-oxo-7-azaspiro[4.5]dec-7-yl]-N-(2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2-yl)acetamide
12/01/2009US7625896 Pyridylsulfonamide derivatives
12/01/2009US7625895 e.g. 5-[rac-cis-2,3-Bis-(4-chloro-phenyl)-5-oxo-2,3-dihydro-5H-imidazo[1,2-a]pyridine-1-sulfonyl]-2-fluoro-benzonitrile; inhibit the interaction of tumor suppressor MDM2 protein with a p53-like peptide; antiproliferative agent; cycle arrest in G1 and G2 phase
12/01/2009US7625894 Pyrrolo[2,3-d]Pyrimidines as Protein Tyrosine Kinase Inhibitors
12/01/2009US7625893 (3S,4R,5R)-3-hydroxymethyl-4-[4-((S)-3-methoxy-2-methyl-propoxymethyl)-phenyl]-5-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo [1,4]oxazin-6-ylmethoxy]-piperidine-1-carboxylic acid benzyl ester; improvement of the pharmacokinetic properties; better bioavailability
12/01/2009US7625891 4-{2-[5-(4,6-Dimethyl-pyrimidine-5-carbonyl)-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl]-ethyl}-4-phenyl-piperidine-1-carboxylic acid tert-butyl ester,chemokine receptor antagonist; human immunodeficiency virus (HIV) infection, AIDS or ARC, antiinflammatory agent, autoimmune diseases, graft v. host disease
12/01/2009US7625889 Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists
12/01/2009CA2508262C Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
11/2009
11/26/2009WO2009143153A1 Substituted pyrrolidine amides as modulators of the histamine h3 receptor
11/26/2009WO2009143049A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
11/26/2009WO2009143039A2 Heterocyclic compounds as factor ixa inhibitors
11/26/2009WO2009142984A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/26/2009WO2009142969A1 Therapeutic lactams
11/26/2009WO2009142569A1 Phenyl or pyridinyl substituted indazoles derivatives
11/26/2009WO2009141782A1 Tetrahydroisoquinolines as antimalarial agents
11/26/2009WO2009141412A1 1,6-disubstituted 3-azabicyclo [3.1.0] hexane derivatives for use as triple reuptake inhibitors
11/26/2009WO2009141274A1 Substituted pyridin-4 -yl-methyl sulfonamides as fungicides
11/26/2009WO2009141096A1 Substituted spiro-isoxazolines
11/26/2009WO2009116729A3 Method for refining of high purity of tacrolimus
11/26/2009US20090292121 Cyanopyridine derivative and use thereof as medicine
11/26/2009US20090292119 Methods for synthesizing benzothiazepine compounds
11/26/2009US20090291991 Isoindoline compounds and methods of their use
11/26/2009US20090291990 Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents
11/26/2009US20090291979 Tricyclic-bridged piperidinylidene derivatives as delta opioid modulators
11/26/2009US20090291970 Substituted Aminoethers for the Treatment of Alzheimer's Disease
11/26/2009US20090291959 Caspase inhibitors based of pyridazinone scaffold
11/26/2009US20090291953 Pharmaceutical salts of reboxetine
11/26/2009US20090291952 Modulators of pharmacokinetic properties of therapeutics
11/26/2009US20090291951 Novel Cyclic Compound Having Pyrimidinylalkylthio Group
11/26/2009US20090291950 Bicyclic heteroaryl inhibitors of pde4
11/26/2009US20090291949 Substitute isoquinolines useful in the treatment of diseases such as cancer and atherosclerosis
11/26/2009US20090291940 Aminopyrrolidine compound
11/26/2009US20090291936 Oxime derivative and preparations thereof
11/26/2009US20090291079 Phosphatidylinositol 3 (PI3); Mammalian Target of Rapamycin, mTOR; triazine compounds substituted with either morpholino or tetrahydropyranyl rings on the triazine ring; anticancer agents, atherosclerosis, bone disorders, psoriasis, BPH, pancreatitis, kidney disease
11/26/2009CA2725140A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/26/2009CA2724584A1 Phenyl or pyridinyl substituted indazoles derivatives
11/26/2009CA2724467A1 Therapeutic lactams
11/26/2009CA2724430A1 Heterocyclic compounds as factor ixa inhibitors
11/26/2009CA2724426A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
11/26/2009CA2723612A1 Tetrahydroisoquinolines as antimalarial agents
11/25/2009EP2123644A1 Benzoxazepine derivatives and use thereof
11/25/2009EP2121659A1 Modulators of cb1 receptors
11/25/2009EP2121652A1 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors
11/25/2009EP2121648A2 S1p receptor modulating compounds and use thereof
11/25/2009EP2121633A2 Piperazine derivatives for treatment of ad and related conditions
11/25/2009EP2121617A1 Cb1 receptor modulators
11/25/2009EP2121608A1 Dihydropyridine derivatives useful as protein kinase inhibitors
11/25/2009EP2120575A1 Sphingosine-1 -phosphate receptor agonist and antagonist compounds
11/25/2009EP2120573A1 Piperidine derivatives
11/25/2009EP1899331B1 Homomorpholine oxazolidinones as antibacterial agents
11/25/2009EP1848694B1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
11/25/2009EP1482932B1 N3 alkylated benzimidazole derivatives as mek inhibitors
11/25/2009EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009EP1144405B1 Triazole compounds with dopamine-d3-receptor affinity
11/25/2009CN101589039A Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase
11/25/2009CN101589038A Heterocyclidene-N-(aryl)acetamide derivative
11/25/2009CN101589037A Heteromonocyclic compound and use thereof
11/25/2009CN101585834A Preparation and use of aromatic heterocyclic methylene BOZ
11/25/2009CN101585833A O-amino-benzamide used for killing arthropods
11/25/2009CN101585817A Method for the effective synthesis of optically active oxazoline-2-ketone derivative
11/25/2009CN101584691A Compounds effecting glucokinase
11/25/2009CN100562518C Novel arylethene-sulfonamides compounds
11/24/2009US7622595 chemical intermediates to insecticides and anticoagulant inhibitors of factor Xa having a 1-halophenyl-3-trifluoromethylpyrazole moeity; 1-(1-chloro-2-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid
11/24/2009US7622579 Hetero isonipecotic modulators of vanilloid VR1 receptor
11/24/2009US7622490 Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
11/24/2009US7622487 Piperidine derivative, process for producing the same, and use
11/24/2009US7622479 For example, 2-(1,3-benzodioxol-5-yl)-6-phenyl-1H-imidazo[4,5-b]pyridinetyrosine; kinase-inhibiting activity; use in treatment of breast cancer, prostate cancer, lung cancer or pancreatic carcinoma
11/24/2009US7622471 Pyrazole derivatives having a pyridazine and pyridine functionality
11/24/2009US7622464 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists
11/24/2009CA2552786C Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
11/24/2009CA2526145C C-glycoside derivatives or salts thereof for use as na+-glucose cotransporter inhibitors
11/24/2009CA2433197C Gyrase inhibitors and uses thereof
11/24/2009CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
11/24/2009CA2415383C New amidino derivatives and their use as thrombin inhibitors
11/24/2009CA2392050C Pharmaceutical formulations containing zolmitriptan
11/19/2009WO2009140466A2 Linezolid co-crystals
11/19/2009WO2009139576A2 Pyridine derivatives substituted with novel benzoxazoles or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical compositions containing the same as active ingredients for prevention and treatment of abnormal cell growth disease
11/19/2009WO2009139373A1 Amide compound
11/19/2009WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009WO2009139340A1 Pyrazole compound
11/19/2009WO2009103007A3 Steroid hormone receptor modulator compounds and methods
11/19/2009WO2009094442A3 5-fluoro pyrimidine derivatives as fungicides
11/19/2009WO2009074300A8 Hedgehog pathway antagonists and therapeutic applications thereof
11/19/2009US20090286985 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same
11/19/2009US20090286868 2-Amino-2-oxoethyl trans-3-[5-(naphth-1-yl)-1,3-dioxan-2-yl]propyl carbamate; reacting the phenylcarbonate with 2-aminodioxane; fatty acid amido hydrolase (FAAH) inhibitors; analgesics; nervous system disorders; gastrointestinal disorders,; to name just a few
11/19/2009US20090286834 Pyridine Analogues VI
1 ... 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 ... 647